123 related articles for article (PubMed ID: 35668940)
1. Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma.
Li Y; Deng Y; Zhang X; Fu H; Han X; Guo W; Zhao W; Zhao X; Yu C; Li H; Lei K; Wang T
Front Pharmacol; 2022; 13():897465. PubMed ID: 35668940
[TBL] [Abstract][Full Text] [Related]
2. Dandelion root extract affects ESCC progression
Duan X; Pan L; Deng Y; Liu Y; Han X; Fu H; Li Y; Li M; Wang T
Food Funct; 2021 Oct; 12(19):9486-9502. PubMed ID: 34476429
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
4. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway.
Zheng TL; Li DP; He ZF; Zhao S
Cancer Cell Int; 2019; 19():250. PubMed ID: 31582906
[TBL] [Abstract][Full Text] [Related]
5. miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
Tian H; Hou L; Xiong YM; Huang JX; She YJ; Bi XB; Song XR
Oncol Rep; 2015 Feb; 33(2):981-9. PubMed ID: 25482044
[TBL] [Abstract][Full Text] [Related]
6. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
[TBL] [Abstract][Full Text] [Related]
7. Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma.
Chi Y; Wang F; Zhang Y; Shan Z; Tao W; Lian Y; Xin D; Fan Q; Sun Y
J Cell Mol Med; 2022 Apr; 26(7):1905-1917. PubMed ID: 35315581
[TBL] [Abstract][Full Text] [Related]
8. Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma.
Zhu X; Li Z; Li T; Long F; Lv Y; Liu L; Liu X; Zhan Q
Biomed Pharmacother; 2018 Jun; 102():502-509. PubMed ID: 29579711
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
10. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
[TBL] [Abstract][Full Text] [Related]
11. Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.
Liao X; Gao Y; Liu J; Tao L; Xie J; Gu Y; Liu T; Wang D; Xie D; Mo S
Front Oncol; 2020; 10():1756. PubMed ID: 33014864
[TBL] [Abstract][Full Text] [Related]
12. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
[TBL] [Abstract][Full Text] [Related]
13. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
15. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].
Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307
[TBL] [Abstract][Full Text] [Related]
16. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.
Chen J; Lan T; Zhang W; Dong L; Kang N; Fu M; Liu B; Liu K; Zhang C; Hou J; Zhan Q
Arch Biochem Biophys; 2015 Jun; 575():38-45. PubMed ID: 25843419
[TBL] [Abstract][Full Text] [Related]
18. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
[No Abstract] [Full Text] [Related]
19. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
20. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
